We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Raises Bar for Pharma Whistleblowers, Citing Need for Solid Proof
Appeals Court Raises Bar for Pharma Whistleblowers, Citing Need for Solid Proof
A federal appeals court has raised the bar for whistleblowers filing False Claims Act (FCA) suits against drugmakers, saying they must provide specific information about the fraudulent claims made, not just broad allegations about a drugmaker’s conduct.